Company Overview 

News & Media

Join Our Team

UNLOCKING THE POTENTIAL
OF TRANSFORMATIVE MEDICINES
FOR OUR CUSTOMERS


Delivering solutions to the biotech and pharmaceutical industry across the entire life-cycle of products, from early development through commercial supply.
 
Contact Us

 

UNLOCKING THE POTENTIAL
OF TRANSFORMATIVE MEDICINES
FOR OUR CUSTOMERS

Delivering solutions to the biotech and pharmaceutical industry across the entire life-cycle of products, from early development through commercial supply.

Contact Us

 

 

ALCAMI EXPANDS BIOPHARMA STORAGE AT MASY BIOSERVICES

NEW FACILITY ADDS 160,000 FT² OF CGMP PALLET STORAGE SPACE

Pepperell, Massachusetts – March 29, 2022 – Alcami, a U.S.-based pharmaceutical contract development and manufacturing organization (CDMO), today announced plans to expand its biostorage footprint at Masy BioServices. Joining the company's existing New England campus is a new 160,000 square-foot facility, purpose-built for cGMP pallet storage space at 15°C to 30°C.

Masy Biostorage
 

ALCAMI ADDS ADDITIONAL FORMULATION DEVELOPMENT CAPABILITIES

FORMULATION DEVELOPMENT SUITE TO SUPPORT SMALL AND LARGE MOLECULE PROGRAMS

Morrisville, North Carolina – March 1, 2022 – Alcami, a U.S.-based pharmaceutical contract development and manufacturing organization (CDMO), announced today the addition of a 3,800 ft² Non-GMP Formulation Development Laboratory (FDL). The dedicated Non-GMP formulation development space, which is co-located within the same facility as Alcami's parenteral manufacturing operation that offers four isolator filling lines for liquid and lyophilized products, is ready to support customers with Preclinical and Clinical development programs.

Vials
 

ALCAMI EXPANDS BIOLOGICS FOOTPRINT WITH INVESTMENT IN DURHAM

$10 MILLION INVESTMENT DOUBLES LABORATORY FOOTPRINT & ENHANCES LARGE MOLECULE AND CELL & GENE THERAPY ANALYTICAL SERVICE OFFERING

Durham, North Carolina – January 27, 2022 – Alcami, a U.S.-based pharmaceutical contract development and manufacturing organization (CDMO), announced today a $10 million investment to expand its laboratory operation in Durham, North Carolina. The investment adds over 6700 ft² to the existing laboratory footprint, new equipment, and capabilities to enhance drug substance and drug product characterization capabilities for biologics in all phases of development, and the capacity to support parenteral manufacturing projects and stand-alone analytical clients.    

Biologics

+0

Years of Experience

+0

Investigational New Drug Filings

+0

Product Launches

+0

Molecules Supported Annually

 

Changing Lives. Creating Cures.

Looking to explore new career opportunities?

Alcami offers a supportive team environment and remarkable scientific expertise to grow your career.

Signing Bonus | Free Healthcare | Bonus Program | 401(k) with Match | College Loan Forgiveness 

If you are looking for a fulfilling workplace, you have come to the right company. Our employees are our biggest resource.

Explore the career opportunities at Alcami today!

Work at Alcami